miRNA regulation of CMAS is bidirectional, yet in pancreatic cancer, the upregulatory miRNAs prevail, which, in conjunction with ST6GAL1 expression, is responsible for the α2-6 sialic acid high phenotype in pancreatic cancer cells (14). The gene discussed is ST6GAL1; the disease is pancreatic neoplasm.